SYNERGY-1: A Phase 1, First-in-Human, Safety, Tolerability, Immunogenicity, Pharmacokinetics, and Pharmacodynamics Study of KP104 in Escalating Single and Multiple Doses: SA-PO636

Saved in:
Bibliographic Details
Published in:Journal of the American Society of Nephrology 2022-11, Vol.33 (11S), p.779-779
Main Authors: Wabnitz, Paul, Gao, Xiang, Ma, Jay, Tsui, Ping, Rabe, Martin, Fu, Helen N., He, Chaomei, Wu, Jingtao, York, Brian K., Weng, Christina, Rankin, Jon, Beddingfield, Frederick C., Song, Wenru, Farinola, Nicholas, Lee, Richard
Format: Article
Language:English
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:1046-6673
DOI:10.1681/ASN.20223311S1779a